GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring (CBGM) technology provides discreet, accurate, real-time glucose readings. The company's ...

Senseonics has revealed promising results for its Eversense technology, a long-term implantable continuous glucose monitoring (CGM) system. The PRECISE II trial looked at the safety and ...

To test the sensor accuracy, the researchers implanted it onto the skin of a hairless diabetic ... Forlenza does research with Medtronic and Dexcom, which both manufacture blood glucose monitoring ...

The Glucotrack Continuous Blood Glucose Monitor is a long-term implantable device for continuous blood glucose monitoring without external components. When will Glucotrack present its trial data?

Glucotrack (Nasdaq:GCTK) may be bringing its continuous blood glucose monitor (CBGM) technology to automated insulin delivery ...

The CBGM is a long-term implantable device with no on-body external component. It is designed to provide three years of continuous, accurate blood glucose monitoring, offering a more convenient and ...

(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that ...

The CBGM is a long-term implantable device with no on-body external component. It is designed to provide three years of continuous, accurate blood glucose monitoring, offering a more convenient ...